Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Ceccarelli

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|July 31, 2025
A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectivenessCarlo Maria Bellanca, Simone Pietro Polosa, Egle Augello, et al.
Haematologica|January 14, 2017
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana LinfomiFrancesco Zaja, Simone Ferrero, Caterina Stelitano, et al.
The New Microbiologica|April 9, 2019
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rateBattistina A V Cama, Manuela Ceccarelli, Emmanuele Venanzi Rullo, et al.
Lancet (London, England)|March 15, 2006
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trialAntonio Palumbo, Sara Bringhen, Tommaso Caravita, et al.
Thrombosis and Haemostasis|April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
The New Microbiologica|October 13, 2018
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rateBattistina A V Cama, Manuela Ceccarelli, Emmanuele Venanzi Rullo, et al.
Blood|October 3, 2013
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive programMarco Ladetto, Chiara Lobetti-Bodoni, Barbara Mantoan, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
AIDS and Behavior|June 5, 2024
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and InclusivityAndrea De Vito, Agnese Colpani, Giulia Moi, et al.
Biomedical Reports|April 7, 2022
Clinical characteristics and predictors of death among hospitalized patients infected with SARS-CoV-2 in Sicily, Italy: A retrospective observational studyFederica Cosentino, Vittoria Moscatt, Andrea Marino, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|July 31, 2025
A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectivenessCarlo Maria Bellanca, Simone Pietro Polosa, Egle Augello, et al.
Haematologica|January 14, 2017
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana LinfomiFrancesco Zaja, Simone Ferrero, Caterina Stelitano, et al.
The New Microbiologica|April 9, 2019
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rateBattistina A V Cama, Manuela Ceccarelli, Emmanuele Venanzi Rullo, et al.
Lancet (London, England)|March 15, 2006
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trialAntonio Palumbo, Sara Bringhen, Tommaso Caravita, et al.
Thrombosis and Haemostasis|April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
The New Microbiologica|October 13, 2018
Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rateBattistina A V Cama, Manuela Ceccarelli, Emmanuele Venanzi Rullo, et al.
Blood|October 3, 2013
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive programMarco Ladetto, Chiara Lobetti-Bodoni, Barbara Mantoan, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
AIDS and Behavior|June 5, 2024
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and InclusivityAndrea De Vito, Agnese Colpani, Giulia Moi, et al.
Biomedical Reports|April 7, 2022
Clinical characteristics and predictors of death among hospitalized patients infected with SARS-CoV-2 in Sicily, Italy: A retrospective observational studyFederica Cosentino, Vittoria Moscatt, Andrea Marino, et al.
Pageof 12